Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG

Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG

These five companies, all trading under $0.10, present speculative opportunities for investors looking to find undervalued businesses with tremendous upside potential. As October unfolds, these stocks may witness significant market movements, offering attractive entry points for those willing to take calculated risks.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), focused on developing novel treatments for central nervous system cancers, has captured investor interest with a promising drug pipeline. CNSP’s stock, trading under $0.10, offers a speculative bet on future oncology breakthroughs, fueled by recent progress in clinical trials.

Qualigen Therapeutics Inc. (NASDAQ: QLGN) continues advancing life-enhancing therapies for cancer and infectious diseases. With its current stock price dipping below $0.10, QLGN represents a compelling buy for those optimistic about the company’s clinical advancements and strategic partnerships.

Akoustis Technologies, Inc. (NASDAQ: AKTS), a leader in RF filter technology, faces market pressure as shares fall below $0.10. However, its core technology and next-generation wireless applications make AKTS an attractive option for tech-focused investors seeking value.

1606 Corp (OTC: CBDW) is making waves by acquiring a strategic stake in Adnexus Biotechnologies to bolster its capabilities in AI-driven drug discovery and infectious disease research, marking a significant move in healthcare and biotechnology.

RJD Green Inc. (OTC: RJDG), with a diversified business model in environmental services, healthcare, and construction, has seen its stock fall below $0.10. For investors seeking exposure to multiple industries, RJDG offers strong speculative potential at this price point.

As these stocks continue to trade under ten cents, they provide unique opportunities for investors ready to embrace risk for the chance of significant returns. With companies like CNS Pharmaceuticals (NASDAQ: CNSP), Qualigen Therapeutics (NASDAQ: QLGN), Akoustis Technologies (NASDAQ: AKTS), 1606 Corp (OTC: CBDW) and RJD Green (OTC: RJDG), showing promise in their respective fields, October 2024 could bring high stakes and rewarding outcomes for those keeping a close watch on these under-the-radar stocks.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com